Avarice Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 17-11-2024
- Paid Up Capital ₹ 0.10 M
as on 17-11-2024
- Company Age 17 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.80 Cr
as on 17-11-2024
- Revenue 656.29%
(FY 2023)
- Profit 306.62%
(FY 2023)
- Ebitda 1282.31%
(FY 2023)
- Net Worth 173.14%
(FY 2023)
- Total Assets 113.72%
(FY 2023)
About Avarice Laboratories
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.80 Cr.
Anita Verma and Ankit Verma serve as directors at the Company.
- CIN/LLPIN
U51109HR2007PTC037136
- Company No.
037136
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Aug 2007
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Karnal, Haryana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Avarice Laboratories Private Limited offer?
Avarice Laboratories Private Limited offers a wide range of products and services, including Industrial Chemicals & Supplies, Plating Chemicals, Industrial Chemicals, Chemical Solvent, Glass Slides, Microscope Slides, Speciality Chemicals, Fertilizers and Soil Additives, Fertilizer, Chemical Reagents & Catalysts.
Who are the key members and board of directors at Avarice Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anita Verma  | Director | 20-Aug-2007 | Current |
| Ankit Verma | Director | 20-Aug-2007 | Current |
Financial Performance of Avarice Laboratories.
Avarice Laboratories Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 656.29% increase. The company also saw a substantial improvement in profitability, with a 306.62% increase in profit. The company's net worth Soared by an impressive increase of 173.14%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Avarice Laboratories?
Unlock access to Avarice Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 07 Sep 2023 | ₹5.00 M | Open |
Others Creation Date: 03 Jan 2023 | ₹2.30 Cr | Open |
How Many Employees Work at Avarice Laboratories?
Avarice Laboratories has a workforce of 8 employees as of Apr 20, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Avarice Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Avarice Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
